Table 3.
Additional outcomes related to blood gas analysis including oximetry and electrolyte data.
| p-values from 2 way ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Condition | Pre | Post-Set 1 | Post-Set 2 | Post-Set 3 | Post-Set 4 | 5 min Post-Ex. | Time | Condition | Interaction | |
| BLOOD GASES/OXIMETRY | ||||||||||
| a-p(O2) [mmHg] | Control | 95 ± 5 | 97 ± 9 | 102 ± 10 | 100 ± 10 | 103 ± 13 | 102 ± 9 | 0.015 | 0.091 | 0.369 |
| BFR | 97 ± 8 | 109 ± 13 | 109 ± 10 | 106 ± 8 | 102 ± 8 | 105 ± 16 | ||||
| a-p(CO2) [mmHg] | Control | 38 ± 3 | 39 ± 4 | 38 ± 4 | 38 ± 3 | 38 ± 3 | 38 ± 3 | 0.7912 | 0.017 | 0.785 |
| BFR | 36 ± 3 | 34 ± 6 | 33 ± 4 | 33 ± 4 | 34 ± 5 | 33 ± 9 | ||||
| a-p50 [mmHg] | Control | 25.8 ± 1.1 | 26.2 ± 0.9 | 26.3 ± 0.9 | 26.8 ± 0.3 | 26.9 ± 0.5 | 26.8 ± 0.6 | 0.009 | 0.105 | 0.133 |
| BFR | 25.7 ± 0.5 | 25.6 ± 2.1 | 25.6 ± 1.9 | 25.7 ± 1.5 | 25.6 ± 0.9 | 26.7 ± 1.4 | ||||
| v-p50 [mmHg] | Control | 27.1 ± 1.5 | 30.2 ± 3.6 | 30.3 ± 2.3 | 30.7 ± 2.0 | 30.2 ± 2.3 | 28.4 ± 1.5 | <0.001 | 0.065 | 0.029 |
| BFR | 27.3 ± 1.7 | 32.3 ± 2.6 | 33.0 ± 2.1 | 32.6 ± 1.8 | 32.2 ± 2.3 | 28.3 ± 2.0 | ||||
| a.ctHb [g·dL−1] | Control | 16.0 ± 1.0 | 16.3 ± 0.9 | 16.3 ± 0.9 | 16.3 ± 0.7 | 16.2 ± 0.9 | 16.2 ± 0.8 | <0.001 | 0.714 | 0.039 |
| BFR | 15.7 ± 1.9 | 16.3 ± 1.3 | 16.6 ± 1.5 | 16.7 ± 1.3 | 16.7 ± 1.3 | 16.4 ± 1.3 | ||||
| v.ctHb [g·dL−1] | Control | 15.6 ± 1.3 | 15.4 ± 1.9 | 16.1 ± 0.8 | 16.6 ± 0.7 | 16.4 ± 0.7 | 15.7 ± 1.1 | <0.001 | 0.045 | 0.239 |
| BFR | 15.6 ± 2.2 | 16.6 ± 1.5 | 17.5 ± 0.6 | 17.5 ± 1.1 | 17.5 ± 1.4 | 15.5 ± 1.8 | ||||
| a.FO2Hb [%] | Control | 97.2 ± 0.7 | 97.2 ± 0.8 | 97.6 ± 0.6 | 97.4 ± 0.4 | 97.5 ± 0.6 | 97.6 ± 0.6 | 0.096 | 0.174 | 0.113 |
| BFR | 97.5 ± 0.6 | 97.9 ± 0.9 | 98 ± 0.7 | 97.9 ± 1.0 | 97.8 ± 0.7 | 97.5 ± 0.5 | ||||
| v.FO2Hb [%] | Control | 78.7 ± 11.2 | 71.4 ± 18.6 | 67.7 ± 17.6 | 66.2 ± 18.9 | 69.9 ± 17.9 | 84.0 ± 8.2 | <0.001 | 0.033 | 0.002 |
| BFR | 76.7 ± 14.4 | 46.1 ± 21.5# | 47.6 ± 18.5 | 49.2 ± 19.7 | 48.4 ± 22.8# | 82.1 ± 13.3 | ||||
| ELECTROLYTES | ||||||||||
| a[K+] [mmol·L−1] | Control | 4.0 ± 0.3 | 4.4 ± 0.2 | 4.3 ± 0.3 | 4.4 ± 0.2 | 4.3 ± 0.4 | 4.0 ± 0.3 | <0.001 | 0.478 | 0.210 |
| BFR | 3.8 ± 0.4 | 4.3 ± 0.3 | 4.4 ± 0.3 | 4.3 ± 0.3 | 4.3 ± 0.4 | 3.8 ± 0.2 | ||||
| a[Na+] [mmol·L−1] | Control | 139.4 ± 1.8 | 139.7 ± 1.9 | 140.0 ± 2.5 | 139.3 ± 1.8 | 138.8 ± 2.2 | 137.7 ± 1.8 | <0.001 | 0.532 | 0.205 |
| BFR | 139.1 ± 2.1 | 138.8 ± 2.0 | 138.8 ± 1.6 | 138.7 ± 1.7 | 138.7 ± 1.9 | 138.0 ± 0.8 | ||||
| a[Ca2+] [mmol·L−1] | Control | 1.21 ± 0.03 | 1.22 ± 0.05 | 1.22 ± 0.05 | 1.23 ± 0.04 | 1.22 ± 0.04 | 1.21 ± 0.04 | 0.217 | 0.334 | 0.194 |
| BFR | 1.19 ± 0.05 | 1.21 ± 0.05 | 1.20 ± 0.04 | 1.21 ± 0.04 | 1.21 ± 0.04 | 1.20 ± 0.04 | ||||
| v[Ca2+] [mmol·L−1] | Control | 1.18 ± 0.10 | 1.21 ± 0.14 | 1.24 ± 0.07 | 1.26 ± 0.05 | 1.24 ± 0.06 | 1.19 ± 0.08 | <0.001 | 0.052 | 0.862 |
| BFR | 1.18 ± 0.11 | 1.30 ± 0.11 | 1.33 ± 0.06 | 1.29 ± 0.09 | 1.30 ± 0.07 | 1.20 ± 0.05 | ||||
| a[Cl−] [mmol·L−1] | Control | 107.8 ± 2.8 | 108.7 ± 1.9 | 109.0 ± 1.8 | 109.2 ± 2.3 | 109.0 ± 2.1 | 108.8 ± 2.2 | 0.023 | 0.622 | 0.235 |
| BFR | 108.3 ± 2.0 | 108.0 ± 2.2 | 109.1 ± 2.0 | 109.4 ± 1.8 | 110.7 ± 5.2 | 109.9 ± 4.0 | ||||
| v[Cl−] [mmol·L−1] | Control | 109.2 ± 4.6 | 110.2 ± 5.3 | 109.1 ± 2.6 | 107.8 ± 2.2 | 108.9 ± 2.5 | 110.1 ± 6.1 | 0.314 | 0.547 | 0.383 |
| BFR | 110.7 ± 5.2 | 108.9 ± 3.9 | 107.7 ± 2.3 | 108.3 ± 2.5 | 107.3 ± 2.2 | 109.0 ± 2.6 | ||||
#
Significantly different between conditions (p <0.05).